61 related articles for article (PubMed ID: 3247594)
1. Studies on the regulation of malignant phenotype and gene expression in human promyelocytic leukemia cell mutant (HL-60-AR).
Xue SP; Liu YH
Sci Sin B; 1988 Sep; 31(9):1095-108. PubMed ID: 3247594
[TBL] [Abstract][Full Text] [Related]
2. [Low-dose recombinant human tumor necrosis-alpha in HL-60 leukemic cell line: effect on induced differentiation and regulating expression of c-myc, c-fos proto-oncogenes].
Yuan YC; Shen SY
Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):666-9, 708-9. PubMed ID: 7866900
[TBL] [Abstract][Full Text] [Related]
3. Double minutes arise from circular extrachromosomal DNA intermediates which integrate into chromosomal sites in human HL-60 leukemia cells.
Von Hoff DD; Forseth B; Clare CN; Hansen KL; VanDevanter D
J Clin Invest; 1990 Jun; 85(6):1887-95. PubMed ID: 2189894
[TBL] [Abstract][Full Text] [Related]
4. Expression of the transforming growth factor alpha protooncogene in differentiating human promyelocytic leukemia (HL-60) cells.
Walz TM; Malm C; Wasteson A
Cancer Res; 1993 Jan; 53(1):191-6. PubMed ID: 7677980
[TBL] [Abstract][Full Text] [Related]
5. Loss of amplified c-myc genes in the spontaneously differentiated HL-60 cells.
Shimizu N; Nakamura H; Kadota T; Kitajima K; Oda T; Hirano T; Utiyama H
Cancer Res; 1994 Jul; 54(13):3561-7. PubMed ID: 8012982
[TBL] [Abstract][Full Text] [Related]
6. Daily addition of an anti-c-myc DNA oligomer induces granulocytic differentiation of human promyelocytic leukemia HL-60 cells in both serum-containing and serum-free media.
Bacon TA; Wickstrom E
Oncogene Res; 1991; 6(1):21-32. PubMed ID: 1997946
[TBL] [Abstract][Full Text] [Related]
7. DMSO-like rapid decrease in c-myc and c-myb mRNA levels and induction of differentiation in HL-60 cells by the anthracycline antitumor antibiotic aclarubicin.
Stöcker U; Schaefer A; Marquardt H
Leukemia; 1995 Jan; 9(1):146-54. PubMed ID: 7845009
[TBL] [Abstract][Full Text] [Related]
8. [Nucleic acid hybridization analysis of the regulatory effect of a cytoplasmic factor on the malignancy of myeloma cells. I. Beta-globin gene expression].
Wang ZQ; Zhang JB; Chen KQ; Zhang SF; Shen Y; Zhang LY; Yuan J; Xue SP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Oct; 9(5):339-45. PubMed ID: 2968857
[No Abstract] [Full Text] [Related]
9. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation.
Kharbanda SM; Sherman ML; Spriggs DR; Kufe DW
Cancer Res; 1988 Nov; 48(21):5965-8. PubMed ID: 2901907
[TBL] [Abstract][Full Text] [Related]
10. Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytes.
Gailani D; Cadwell FJ; O'Donnell PS; Hromas RA; Macfarlane DE
Cancer Res; 1989 Oct; 49(19):5329-33. PubMed ID: 2670202
[TBL] [Abstract][Full Text] [Related]
11. Transient down-regulation of c-myc protooncogene expression by the alkaloid nicotine in human promyelocytic HL-60 cells.
Maturana JA; Fraioli M; Wu JM
Biochem Int; 1991 Jun; 24(3):549-57. PubMed ID: 1772432
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule inhibitors of c-Myc transcriptional factor suppress proliferation and induce apoptosis of promyelocytic leukemia cell via cell cycle arrest.
Jeong KC; Ahn KO; Yang CH
Mol Biosyst; 2010 Aug; 6(8):1503-9. PubMed ID: 20485733
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of proto-oncogene c-myc expression with recombinant human tumor necrosis factor-alpha and interferon-gamma in HL-60 cell lines and acute myelocytic leukemic fresh cells].
Yuan YC; Shen SY
Zhonghua Nei Ke Za Zhi; 1994 May; 33(5):302-5. PubMed ID: 7835139
[TBL] [Abstract][Full Text] [Related]
14. Loss of amplification and appearance of a novel translocation site of the c-myc oncogene in HL-60 leukemia cells.
Donti E; Lanfrancone L; Pelicci PG; Birnie GD; Dalla-Favera R
Cancer Genet Cytogenet; 1991 Oct; 56(1):57-64. PubMed ID: 1747869
[TBL] [Abstract][Full Text] [Related]
15. Studies on the cell phenotype characteristics of hybrid cells crossed between rat nucleated erythroblasts and mouse plasmocytoma (SP2/O) cell line.
Zhang QY; Xue SP
Sci China B; 1990 May; 33(5):572-83. PubMed ID: 2390164
[TBL] [Abstract][Full Text] [Related]
16. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
[TBL] [Abstract][Full Text] [Related]
17. Expression of selected genes and oncogenes in differentiated HL-60 cells and primary cells from human leukemias.
Shiosaka T; Tanaka Y
Anticancer Res; 1989; 9(5):1249-64. PubMed ID: 2589822
[TBL] [Abstract][Full Text] [Related]
18. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
19. Regulated expression of the c-myb and c-myc oncogenes during erythroid differentiation.
Kirsch IR; Bertness V; Silver J; Hollis GF
J Cell Biochem; 1986; 32(1):11-21. PubMed ID: 3464612
[TBL] [Abstract][Full Text] [Related]
20. DNA repair in the MYC and FMS proto-oncogenes in ultraviolet light-irradiated human HL60 promyelocytic cells during differentiation.
Islas AL; Hanawalt PC
Cancer Res; 1995 Jan; 55(2):336-41. PubMed ID: 7529133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
